News & Events | QuidelOrtho

Recent press releases

Press Release 09/21/23

Quidelortho Receives CLIA Waiver For Sofia^® 2 SARS Antigen+ FIA

Press Release 08/28/23

QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Press Release 08/11/23

QuidelOrtho Appoints Juliet Cunningham As Vice President Of Investor Relations

Press Release 11/16/23

QuidelOrtho to Participate in the Evercore ISI Conference

Press Release 11/01/23

QuidelOrtho Reports Third Quarter 2023 Financial Results

Press Release 10/12/23

QuidelOrtho Reports Preliminary Revenue Results For The Third Quarter 2023

Press Release 09/21/23

Quidelortho Receives CLIA Waiver For Sofia^® 2 SARS Antigen+ FIA

Press Release 08/28/23

QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Press Release 08/11/23

QuidelOrtho Appoints Juliet Cunningham As Vice President Of Investor Relations

Press Release 11/16/23

QuidelOrtho to Participate in the Evercore ISI Conference

Press Release 11/01/23

QuidelOrtho Reports Third Quarter 2023 Financial Results

Press Release 10/12/23

QuidelOrtho Reports Preliminary Revenue Results For The Third Quarter 2023

Recent press releases

QuidelOrtho to Participate in the Evercore ISI Conference

QuidelOrtho Reports Third Quarter 2023 Financial Results

QuidelOrtho Reports Preliminary Revenue Results For The Third Quarter 2023

All news

undefined (120)

Pageof10

Press Release

QuidelOrtho to Participate in the Evercore ISI Conference

Press Release

QuidelOrtho Reports Third Quarter 2023 Financial Results

Press Release

QuidelOrtho Reports Preliminary Revenue Results For The Third Quarter 2023

Press Release

Quidelortho Receives CLIA Waiver For Sofia^® 2 SARS Antigen+ FIA

Press Release

QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Press Release

QuidelOrtho Appoints Juliet Cunningham As Vice President Of Investor Relations

Press Release

QuidelOrtho Reports Second Quarter 2023 Financial Results

Press Release

QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row

Press Release

QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings

Press Release

QuidelOrtho to Report Second Quarter 2023 Financial Results

Press Release

QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference

Press Release

QuidelOrtho Receives FDA De Novo Classification for Two SARS-CoV-2 Antibody Tests

Pageof10

Legal Notice

By accessing, browsing, and/or using this website, you acknowledge that you have read, understood, and agree to be bound by QuidelOrtho’s Website Terms of Use, Privacy Notice and to comply with all applicable laws and regulations. If you do not agree to these terms, do not use the website. Additionally, the website contains information on products that is targeted to many different audiences and could contain product details or information otherwise not accessible or valid in your country. Product availability may vary from country to country and is subject to varying regulatory requirements. New QuidelOrtho branding may not be available in all markets, subject to country specific regulatory approval. Please be aware that we do not take any responsibility for your accessing such information that may not comply with any legal process, regulation, registration, or usage in the country of your origin.

©2025 QuidelOrtho Corporation. All rights reserved.

QuidelOrtho Corporation
9975 Summers Ridge Road, San Diego, CA 92121, USA